Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 3:32 pm Sale | 13G | Akouos Inc. AKUS | Beryl Capital Management LLC | 0 0.000% | -3,041,466 (Position Closed) | View |
2023-02-10 1:59 pm Sale | 13G | Akouos Inc. AKUS | EcoR1 Capital LLC | 0 0.000% | -1,975,984 (Position Closed) | View |
2023-01-10 12:48 pm Sale | 13G | Akouos Inc. AKUS | FMR LLC | 416,512 1.127% | -3,787,311 (-90.09%) | View |
2023-01-10 08:31 am Sale | 13G | Akouos Inc. AKUS | FEDERATED HERMES INC. FHI | 0 0.000% | -3,897,903 (Position Closed) | View |
2022-12-02 3:35 pm Sale | 13D | Akouos Inc. AKUS | 5AM Ventures V L.P. | 0 0.000% | -4,135,784 (Position Closed) | View |
2022-12-01 4:11 pm Sale | 13D | Akouos Inc. AKUS | ELI LILLY & Co LLY | 100 100.000% | -9,639,089 (-100.00%) | View |
2022-10-28 4:48 pm Unchanged | 13D | Akouos Inc. AKUS | New Enterprise Associates 16 L.P. | 4,294,207 11.600% | 0 (Unchanged) | View |
2022-10-28 4:17 pm Purchase | 13G | Akouos Inc. AKUS | Beryl Capital Management LLC | 3,041,466 8.200% | 3,041,466 (New Position) | View |
2022-10-27 4:31 pm Purchase | 13D | Akouos Inc. AKUS | ELI LILLY & Co LLY | 9,639,189 25.500% | 9,639,189 (New Position) | View |
2022-09-09 11:01 am Purchase | 13G | Akouos Inc. AKUS | FEDERATED HERMES INC. FHI | 3,897,903 10.560% | 1,399,461 (+56.01%) | View |
2022-08-25 4:07 pm Unchanged | 13G | Akouos Inc. AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 4.900% | 0 (Unchanged) | View |
2022-08-15 5:04 pm Sale | 13G | Akouos Inc. AKUS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,281,249 (Position Closed) | View |
2022-07-08 4:57 pm Sale | 13G | Akouos Inc. AKUS | BlackRock Inc. BLK | 782,709 2.300% | -1,203,237 (-60.59%) | View |
2022-05-23 4:30 pm Purchase | 13G | Akouos Inc. AKUS | Venrock Healthcare Capital Partners II L.P. | 2,391,545 6.900% | 2,391,545 (New Position) | View |
2022-02-14 4:11 pm Unchanged | 13G | Akouos Inc. AKUS | RA CAPITAL MANAGEMENT L.P. | 2,281,249 6.600% | 0 (Unchanged) | View |
2022-02-14 1:35 pm Purchase | 13G | Akouos Inc. AKUS | FEDERATED HERMES INC. FHI | 2,498,442 7.240% | 178,960 (+7.72%) | View |
2022-02-14 09:18 am Unchanged | 13G | Akouos Inc. AKUS | Pivotal bioVenture Partners Fund I L.P. | 1,794,088 5.200% | 0 (Unchanged) | View |
2022-02-09 09:09 am Purchase | 13G | Akouos Inc. AKUS | FMR LLC | 4,203,823 12.187% | 15,954 (+0.38%) | View |
2022-02-04 4:12 pm Purchase | 13G | Akouos Inc. AKUS | BlackRock Inc. BLK | 1,985,946 5.800% | 1,985,946 (New Position) | View |
2021-02-16 4:39 pm Purchase | 13G | Akouos Inc. AKUS | RA CAPITAL MANAGEMENT L.P. | 2,281,249 6.600% | 2,281,249 (New Position) | View |